Patents by Inventor Ken Phares

Ken Phares has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • TREPROSTINIL PRODRUGS
    Publication number: 20230255922
    Abstract: Provided are novel prodrugs of treprostinil, as well as methods of making and methods of using these prodrugs.
    Type: Application
    Filed: April 28, 2023
    Publication date: August 17, 2023
    Applicant: United Therapeutics Corporation
    Inventors: Ken PHARES, Hitesh BATRA, Liang GUO, Adam Marc SILVERSTEIN
  • Treprostinil prodrugs
    Patent number: 11672775
    Abstract: Provided are novel prodrugs of treprostinil, as well as methods of making and methods of using these prodrugs.
    Type: Grant
    Filed: January 4, 2021
    Date of Patent: June 13, 2023
    Assignee: United Therapeutics Corporation
    Inventors: Ken Phares, Hitesh Batra, Liang Guo, Adam Marc Silverstein
  • COMPOUNDS AND METHODS FOR DELIVERY OF PROSTACYCLIN ANALOGS
    Publication number: 20220289660
    Abstract: This invention pertains generally to prostacyclin formulations and methods for their use in promoting vasodilation, inhibiting platelet aggregation and thrombus formation, stimulating thrombolysis, inhibiting cell proliferation (including vascular remodeling), providing cytoprotection, preventing atherogenesis and inducing
    Type: Application
    Filed: April 4, 2022
    Publication date: September 15, 2022
    Applicant: United Therapeutics Corporation
    Inventor: Ken PHARES
  • Compounds and methods for delivery of prostacyclin analogs
    Patent number: 11292758
    Abstract: This invention pertains generally to prostacyclin formulations and methods for their use in promoting vasodilation, inhibiting platelet aggregation and thrombus formation, stimulating thrombolysis, inhibiting cell proliferation (including vascular remodeling), providing cytoprotection, preventing atherogenesis and inducing angiogenesis.
    Type: Grant
    Filed: October 6, 2021
    Date of Patent: April 5, 2022
    Assignee: United Therapeutics Corporation
    Inventor: Ken Phares
  • COMPOUNDS AND METHODS FOR DELIVERY OF PROSTACYCLIN ANALOGS
    Publication number: 20220024845
    Abstract: This invention pertains generally to prostacyclin formulations and methods for their use in promoting vasodilation, inhibiting platelet aggregation and thrombus formation, stimulating thrombolysis, inhibiting cell proliferation (including vascular remodeling), providing cytoprotection, preventing atherogenesis and inducing
    Type: Application
    Filed: October 6, 2021
    Publication date: January 27, 2022
    Applicant: United Therapeutics Corporation
    Inventor: Ken PHARES
  • TREPROSTINIL PRODRUGS
    Publication number: 20210121433
    Abstract: Provided are novel prodrugs of treprostinil, as well as methods of making and methods of using these prodrugs.
    Type: Application
    Filed: January 4, 2021
    Publication date: April 29, 2021
    Applicant: United Therapeutics Corporation
    Inventors: Ken PHARES, Hitesh BATRA, Liang GUO, Adam Marc SILVERSTEIN
  • Compounds and methods for delivery of prostacyclin analogs
    Patent number: 10947177
    Abstract: This invention pertains generally to prostacyclin formulations and methods for their use in promoting vasodilation, inhibiting platelet aggregation and thrombus formation, stimulating thrombolysis, inhibiting cell proliferation (including vascular remodeling), providing cytoprotection, preventing atherogenesis and inducing angiogenesis.
    Type: Grant
    Filed: July 23, 2019
    Date of Patent: March 16, 2021
    Assignee: United Therapeutics Corporation
    Inventor: Ken Phares
  • COMPOUNDS AND METHODS FOR DELIVERY OF PROSTACYCLIN ANALOGS
    Publication number: 20200181057
    Abstract: This invention pertains generally to prostacyclin formulations and methods for their use in promoting vasodilation, inhibiting platelet aggregation and thrombus formation, stimulating thrombolysis, inhibiting cell proliferation (including vascular remodeling), providing cytoprotection, preventing atherogenesis and inducing angiogenesis.
    Type: Application
    Filed: February 7, 2020
    Publication date: June 11, 2020
    Applicant: United Therapeutics Corporation
    Inventor: Ken Phares
  • COMPOUNDS AND METHODS FOR DELIVERY OF PROSTACYCLIN ANALOGS
    Publication number: 20190345091
    Abstract: This invention pertains generally to prostacyclin formulations and methods for their use in promoting vasodilation, inhibiting platelet aggregation and thrombus formation, stimulating thrombolysis, inhibiting cell proliferation (including vascular remodeling), providing cytoprotection, preventing atherogenesis and inducing angiogenesis.
    Type: Application
    Filed: July 23, 2019
    Publication date: November 14, 2019
    Applicant: United Therapeutics Corporation
    Inventor: Ken Phares
  • TREPROSTINIL PRODRUGS
    Publication number: 20180153847
    Abstract: Provided are novel prodrugs of treprostinil, as well as methods of making and methods of using these prodrugs.
    Type: Application
    Filed: September 26, 2017
    Publication date: June 7, 2018
    Applicant: United Therapeutics Corporation
    Inventors: Ken PHARES, Hitesh BATRA, Liang GUO, Adam Marc SILVERSTEIN
  • COMPOUNDS AND METHODS FOR DELIVERY OF PROSTACYCLIN ANALOGS
    Publication number: 20180141891
    Abstract: This invention pertains generally to prostacyclin formulations and methods for their use in promoting vasodilation, inhibiting platelet aggregation and thrombus formation, stimulating thrombolysis, inhibiting cell proliferation (including vascular remodeling), providing cytoprotection, preventing atherogenesis and inducing angiogenesis.
    Type: Application
    Filed: January 19, 2018
    Publication date: May 24, 2018
    Applicant: United Therapeutics Corporation
    Inventor: Ken Phares
  • Compounds and methods for delivery of prostacyclin analogs
    Patent number: 9878972
    Abstract: This invention pertains generally to prostacyclin formulations and methods for their use in promoting vasodilation, inhibiting platelet aggregation and thrombus formation, stimulating thrombolysis, inhibiting cell proliferation (including vascular remodeling), providing cytoprotection, preventing atherogenesis and inducing angiogenesis.
    Type: Grant
    Filed: August 17, 2016
    Date of Patent: January 30, 2018
    Assignee: United Therapeutics Corporation
    Inventors: Ken Phares, David Mottola
  • Solid forms of treprostinil
    Patent number: 9822057
    Abstract: There is provided individual polymorphic forms of treprostinil and pharmaceutical formulations comprising the same, methods of making and using the same.
    Type: Grant
    Filed: March 7, 2014
    Date of Patent: November 21, 2017
    Assignee: United Therapeutics Corporation
    Inventors: Ken Phares, Michael Scannell
  • Compounds and methods for delivery of prostacyclin analogs
    Patent number: 9624156
    Abstract: This invention pertains generally to prostacyclin formulations and methods for their use in promoting vasodilation, inhibiting platelet aggregation and thrombus formation, stimulating thrombolysis, inhibiting cell proliferation (including vascular remodeling), providing cytoprotection, preventing atherogenesis and inducing angiogenesis.
    Type: Grant
    Filed: October 28, 2015
    Date of Patent: April 18, 2017
    Assignee: United Therapeutics Corporation
    Inventors: Ken Phares, David Mottola, Roger Jeffs
  • TREPROSTINIL FORMULATIONS
    Publication number: 20170095432
    Abstract: Provided are ion complexes comprising treprostinil and an ion-exchange resin, pharmaceutical formulations based on such complexes, and methods of treating diseases and conditions using the ion complexes and pharmaceutical formulations.
    Type: Application
    Filed: June 12, 2015
    Publication date: April 6, 2017
    Applicant: United Therapeutics Corporation
    Inventors: Ken PHARES, Courtney CHANG
  • COMPOUNDS AND METHODS FOR DELIVERY OF PROSTACYCLIN ANALOGS
    Publication number: 20160355455
    Abstract: This invention pertains generally to prostacyclin formulations and methods for their use in promoting vasodilation, inhibiting platelet aggregation and thrombus formation, stimulating thrombolysis, inhibiting cell proliferation (including vascular remodeling), providing cytoprotection, preventing atherogenesis and inducing angiogenesis.
    Type: Application
    Filed: August 17, 2016
    Publication date: December 8, 2016
    Applicant: United Therapeutics Corporation
    Inventors: Ken Phares, David Mottola
  • Compounds and methods for delivery of prostacyclin analogs
    Patent number: 9422223
    Abstract: This invention pertains generally to prostacyclin formulations and methods for their use in promoting vasodilation, inhibiting platelet aggregation and thrombus formation, stimulating thrombolysis, inhibiting cell proliferation (including vascular remodeling), providing cytoprotection, preventing atherogenesis and inducing angiogenesis.
    Type: Grant
    Filed: October 13, 2015
    Date of Patent: August 23, 2016
    Assignee: United Therapeutics Corporation
    Inventors: Ken Phares, David Mottola, Roger Jeffs
  • Compounds and methods for delivery of prostacyclin analogs
    Patent number: 9278901
    Abstract: This invention pertains generally to prostacyclin formulations and methods for their use in promoting vasodilation, inhibiting platelet aggregation and thrombus formation, stimulating thrombolysis, inhibiting cell proliferation (including vascular remodeling), providing cytoprotection, preventing atherogenesis and inducing angiogenesis.
    Type: Grant
    Filed: May 13, 2015
    Date of Patent: March 8, 2016
    Assignee: United Therapeutics Corporation
    Inventors: Ken Phares, David Mottola, Roger Jeffs
  • COMPOUNDS AND METHODS FOR DELIVERY OF PROSTACYCLIN ANALOGS
    Publication number: 20160051505
    Abstract: This invention pertains generally to prostacyclin formulations and methods for their use in promoting vasodilation, inhibiting platelet aggregation and thrombus formation, stimulating thrombolysis, inhibiting cell proliferation (including vascular remodeling), providing cytoprotection, preventing atherogenesis and inducing angiogenesis.
    Type: Application
    Filed: October 28, 2015
    Publication date: February 25, 2016
    Applicant: United Therapeutics Corporation
    Inventors: Ken Phares, David MOTTOLA, Roger JEFFS
  • COMPOUNDS AND METHODS FOR DELIVERY OF PROSTACYCLIN ANALOGS
    Publication number: 20160030371
    Abstract: This invention pertains generally to prostacyclin formulations and methods for their use in promoting vasodilation, inhibiting platelet aggregation and thrombus formation, stimulating thrombolysis, inhibiting cell proliferation (including vascular remodeling), providing cytoprotection, preventing atherogenesis and inducing angiogenesis.
    Type: Application
    Filed: October 13, 2015
    Publication date: February 4, 2016
    Applicant: United Therapeutics Corporation
    Inventors: Ken Phares, David Mottola, Roger Jeffs